UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6001
Arrow Financial
AROW
$652M
| $390K | ﹤0.01% |
13,582
+5,082
| +60% | +$155K |
|
|
DRD
6002
DRDGold
DRD
$2.05B
| $390K | ﹤0.01% |
45,150
-4,480
| -9% | -$45.5K |
|
6003
John Marshall Bancorp
JMSB
$329M
| $390K | ﹤0.01% |
19,399
+4,693
| +32% | +$103K |
|
6004
Invesco Bloomberg Pricing Power ETF
POWA
$183M
| $388K | ﹤0.01% |
4,780
+13
| +0.3% | +$1.1K |
|
6005
NewtekOne
NEWT
$391M
| $388K | ﹤0.01% |
30,398
+9,421
| +45% | +$128K |
|
|
TEF
6006
DELISTED
Telefonica
TEF
| $388K | ﹤0.01% |
96,434
+7,244
| +8% | +$32.6K |
|
6007
PUT
Sempra
SRE
$54.8B
| $386K | ﹤0.01% |
+4,400
| New | +$385K |
|
6008
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
| $386K | ﹤0.01% |
16,357
+6,103
| +60% | +$145K |
|
6009
Gilat Satellite Networks
GILT
$848M
| $385K | ﹤0.01% |
+62,638
| New | +$341K |
|
6010
VirTra
VTSI
$34.5M
| $385K | ﹤0.01% |
57,046
+49,181
| +625% | +$332K |
|
6011
CALL
AeroVironment
AVAV
$9.45B
| $385K | ﹤0.01% |
+2,500
| New | +$489K |
|
6012
PUT
Canadian Solar
CSIQ
$1.08B
| $384K | ﹤0.01% |
+34,500
| New | +$445K |
|
6013
Belpointe PREP
OZ
$183M
| $383K | ﹤0.01% |
4,950
| – | – |
|
6014
CALL
Vornado Realty Trust
VNO
$7.38B
| $383K | ﹤0.01% |
9,100
-90,900
| -91% | -$3.84M |
|
|
NOTE
6015
DELISTED
FiscalNote
NOTE
| $382K | ﹤0.01% |
29,735
+27,349
| +1,146% | +$333K |
|
6016
E.W. Scripps
SSP
$304M
| $382K | ﹤0.01% |
172,746
+39,751
| +30% | +$91.8K |
|
|
HURA
6017
TuHURA Biosciences
HURA
$136M
| $382K | ﹤0.01% |
93,333
+90,368
| +3,048% | +$480K |
|
6018
PUT
Mohawk Industries
MHK
$9.22B
| $381K | ﹤0.01% |
+3,200
| New | +$447K |
|
|
ASG
6019
Liberty All-Star Growth Fund
ASG
$341M
| $381K | ﹤0.01% |
67,469
-2,303
| -3% | -$13.3K |
|
6020
Eastern Company
EML
$150M
| $380K | ﹤0.01% |
14,329
+6,302
| +79% | +$188K |
|
|
RAPP
6021
Rapport Therapeutics
RAPP
$2.18B
| $378K | ﹤0.01% |
21,328
+15,771
| +284% | +$349K |
|
|
ALMS
6022
Alumis Inc
ALMS
$3.52B
| $378K | ﹤0.01% |
48,118
+40,514
| +533% | +$406K |
|
|
APLT
6023
DELISTED
Applied Therapeutics
APLT
| $378K | ﹤0.01% |
441,769
+158,084
| +56% | +$991K |
|
6024
Dogness International Corp
DOGZ
$13.4M
| $378K | ﹤0.01% |
8,311
+6,279
| +309% | +$282K |
|
6025
Solid Biosciences
SLDB
$900M
| $378K | ﹤0.01% |
94,467
+82,471
| +687% | +$453K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.